GLOBAL LIQUID BIOPSY MARKET RESEARCH REPORT, 2023-2030
Market Value:
• 2021 = USD 1.32 Billion
• 2028 = USD4.79 Billion
• CAGR = 20.2%
Date Published: January 2023
Publisher: Introspective Market Research
Annual Market Size and Forecast
Technological Roadmap & Regulatory Landscape
Analysis on type and applications
Industry Value Chain Analysis
Analysis on Major Trends
Key strategies by Top Market Players
Market Share Analysis 2021
A liquid biopsy is a simple and non-invasive alternative to surgical biopsies that allows doctors to learn about tumors from a simple blood sample. In 1994, scientists advanced to the point where they could detect specific mutations in cfDNA. Dennis Lo discovered fetal cfDNA in the blood in 1997, and Veridex released the first commercially available liquid biopsy assay, the CELL SEARCH CTC test, in 2000. The FDA approved the first liquid biopsy test, the Cobas EGFR Mutation Test, as a cfDNA test for the EGFR gene mutation in lung cancer patients' blood in June 2016.
Read More: https://introspectivemarketresearch.com/reports/liquid-biopsy-market/
Global Liquid Biopsy Market was valued at USD 1.32 billion in 2021 and is expected to reach USD 4.79 billion by the year 2028, at a CAGR of 20.2%.
With In-Depth examination of several affecting internal and external factors such as supply and sales channels, including upstream and downstream fundamentals, this report presents a complete analysis on the keyword market ecosystem. To ensure the utmost accuracy and reliability, we draw upon numerous primary and secondary sources. Employing industry-standard tools such as Porter's Five Forces Analysis, SWOT Analysis, and Price Trend Analysis, our research provides a comprehensive evaluation of the market segments and market landscape. This research study goes beyond conventional boundaries with extensive geographical coverage, allowing for a comprehensive understanding of regional trends.
Some of the key players profiled in the study are:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Myriad Genetics Inc. (US)
• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific Inc. (the US)
• Guardant Health Inc. (the US)
• BIOCEPT Inc. (the US)
• Illumina Inc. (the US)
• Angle plc (UK)
• Oncimmune(UK)
• Lucence health Inc. (US)
• FreenomeHoldings Inc. (US) and Other Major Players.
Download Free Sample: https://introspectivemarketresearch.com/request/16300
Liquid Biopsy Market: Demand Analysis & Opportunity Outlook 2029
Liquid Biopsy research study defines market size of various segments & countries by historical years and forecast the values for next 6 years. The report is assembled to comprise qualitative and quantitative elements of Liquid Biopsy industry including: market share, market size (value and volume 2017-2022, and forecast to 2029) that admires each country concerned in the competitive marketplace. Further, the study also caters and provides in-depth statistics about the crucial elements of Liquid Biopsy which includes drivers & restraining factors that helps estimate future growth outlook of the market.
The segments and sub-section of Liquid Biopsy market is shown below:
By Cancer Type•
Lung• Breast
• Liver
• Others
By End-User• Hospitals
• Laboratories
• Government Research Centre
Have Any Query? Ask Our Expert @: https://introspectivemarketresearch.com/inquiry/16300
By Region
• North America (U.S., Canada, Mexico)
• Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
• Western Europe (Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
• Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
• Middle East & Africa (Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)
• South America (Brazil, Argentina, Rest of SA)
Covid-19 Impact Analysis On Liquid Biopsy Market
The global pandemic of COVID-19 has slowed the growth rate of the liquid biopsy market from 2020 to 2021. The novel influenza coronavirus (SARS-CoV-2) has disrupted many aspects of our lives, including medical activities. In this setting, much routine cancer diagnostic and therapeutic procedures have been suspended, leading to delays in diagnosis, treatments, and, ultimately, increases in cancer mortality rates. Equally drastic has been the impact of COVID-19 on clinical trials. The pandemic has also impacted the logistics and supplies of cancer diagnostic raw materials and components and other essential commodities utilized in the assembly of liquid biopsy. These factors limit the growth of the liquid biopsy market during the COVID-19 pandemic.
Reasons to buy
• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying Top Manufacturers.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
Read More Report:
https://introspectivemarketresearch.com/reports/emergency-contraceptive-pills-market/
https://introspectivemarketresearch.com/reports/data-center-ups-market/
https://introspectivemarketresearch.com/reports/enterprise-data-center-edc-market/
https://introspectivemarketresearch.com/reports/stationary-electric-vehicle-charging-gun-market/
https://introspectivemarketresearch.com/reports/multiple-sclerosis-drugs-market/
https://introspectivemarketresearch.com/reports/us-potato-chips-market/
https://introspectivemarketresearch.com/reports/pvc-film-for-medical-market-market/
Buy-Now this Premium Report (������������%
����������������):https://introspectivemarketresearch.com/checkout/?user=1&_sid=16300
Table Of Content: -
Chapter1:Introduction
1.1ResearchObjectives
1.2ResearchMethodology
1.3ResearchProcess
1.4ScopeandCoverage
1.4.1MarketDefinition
1.4.2KeyQuestionsAnswered
1.5MarketSegmentation
Chapter2:ExecutiveSummary
Chapter3:GrowthOpportunitiesBySegment
3.1ByCancerType
3.2ByCirculatingBiomarker
3.3ByEnd-User
Chapter4:MarketLandscape
4.1Porter'sFiveForcesAnalysis
4.1.1BargainingPowerofSupplier
4.1.2ThreatofNewEntrants
4.1.3ThreatofSubstitutes
4.1.4CompetitiveRivalry
4.1.5BargainingPowerAmongBuyers
4.2IndustryValueChainAnalysis
4.3MarketDynamics
4.3.1Drivers
4.3.2Restraints
4.3.3Opportunities
4.5.4Challenges
4.4PestleAnalysis
4.5TechnologicalRoadmap
4.6RegulatoryLandscape
4.7SWOTAnalysis
4.8PriceTrendAnalysis
4.9PatentAnalysis
4.10AnalysisoftheImpactofCovid-19
4.10.1ImpactontheOverallMarket
4.10.2ImpactontheSupplyChain
4.10.3ImpactontheKeyManufacturers
4.10.4ImpactonthePricing
Chapter5:LiquidBiopsyMarketbyCancerType
5.1LiquidBiopsyMarketOverviewSnapshotandGrowthEngine
5.2LiquidBiopsyMarketOverview
5.3LungCancer
5.3.1IntroductionandMarketOverview
5.3.2HistoricandForecastedMarketSize(2016-2028F)
5.3.3KeyMarketTrends,GrowthFactorsandOpportunities
5.3.4LungCancer:GrographicSegmentation
5.4BreastCancer
5.4.1IntroductionandMarketOverview
5.4.2HistoricandForecastedMarketSize(2016-2028F)
5.4.3KeyMarketTrends,GrowthFactorsandOpportunities
5.4.4BreastCancer:GrographicSegmentation
5.5LiverCancer
5.5.1IntroductionandMarketOverview
5.5.2HistoricandForecastedMarketSize(2016-2028F)
5.5.3KeyMarketTrends,GrowthFactorsandOpportunities
5.5.4LiverCancer:GrographicSegmentation
5.6Others
5.6.1IntroductionandMarketOverview
5.6.2HistoricandForecastedMarketSize(2016-2028F)
5.6.3KeyMarketTrends,GrowthFactorsandOpportunities
5.6.4Others:GrographicSegmentation
Chapter6:LiquidBiopsyMarketbyCirculatingBiomarker
6.1LiquidBiopsyMarketOverviewSnapshotandGrowthEngine
6.2LiquidBiopsyMarketOverview
6.3CirculatingTumorDNA
6.3.1IntroductionandMarketOverview
6.3.2HistoricandForecastedMarketSize(2016-2028F)
6.3.3KeyMarketTrends,GrowthFactorsandOpportunities
6.3.4CirculatingTumorDNA:GrographicSegmentation
6.4CirculatingTumorCells 6.4.1IntroductionandMarketOverview 6.4.2HistoricandForecastedMarketSize(2016-2028F)
6.4.3KeyMarketTrends,GrowthFactorsandOpportunities
6.4.4CirculatingTumorCells:GrographicSegmentation 6.5Other 6.5.1IntroductionandMarketOverview
6.5.2HistoricandForecastedMarketSize(2016-2028F)
6.5.3KeyMarketTrends,GrowthFactorsandOpportunities 6.5.4Other:GrographicSegmentation
Chapter7:LiquidBiopsyMarketbyEnd-User 7.1LiquidBiopsyMarketOverviewSnapshotandGrowthEngine
(2016-2028F)
7.3.3KeyMarketTrends,GrowthFactorsandOpportunities 7.3.4Hospitals:GrographicSegmentation 7.4Laboratories
7.4.2HistoricandForecastedMarketSize(2016-2028F) 7.4.3KeyMarketTrends,GrowthFactorsandOpportunities
7.4.4Laboratories:GrographicSegmentation
7.5GovernmentResearchCenters
7.5.1IntroductionandMarketOverview
7.5.2HistoricandForecastedMarketSize(2016-2028F)
7.5.3KeyMarketTrends,GrowthFactorsandOpportunities
7.5.4GovernmentResearchCenters:GrographicSegmentation
To Be Continued… About Us:
We are a global market research company, specialized in using big data and advanced analytics with strategic consulting to help our clients get acclimatize with the future market trends. Our experts at IMR help our clients gain knowledge about the past and present market condition to gain a holistic idea about the future.
We are a technology-driven research company with strategic analysis. We analyse extremely large sets of data to discover deeper insights and provide conclusive consulting. Our core niches are performing regional demand and estimation and forecasting, Customer Relationship Management and Product sourcing strategy, Competitive and Landscape Analysis, Cost Benefits, Demand-Supply Analysis, Mergers and Acquisitions.
We believe it is important to have the certain knowledge about the past and present data to have a better understanding about the future. The statistics from past and present that our team at IMR analyse will help our clientele have a better knowledge about investing in future. Introspective Market Research offers expert guidance and deeper insights with utmost accuracy to have a deep understanding about the clients need and to help them achieve a successful business.
Our in-depth knowledge of various industries, innovative methodology, and collaborations with global research companies capacitate us to fulfil the unique requirements of diverse clients with even diversifies market. A through assessment is done to analyse the ‘ins and outs’ of the market, to analyse the opportunities and the weaknesses of the market.
We assist our clients to create sublime strategies to achieve their targets. Our team at IMR can guide you help recognizing the trends in the market and opportunity for future growth that will promise an impactful future for your business venture.
Terms of Use:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
